La Jolla Pharmaceutical Co (LJPC)

[FatCat_Banker]

I guess Chardan is assuming fast-track to approval status. There's no way it was terminated due to efficacy with a p-vaule of 0.100 in a single-blinded study. Not that they won't meet it, but I think the requirement is > 0.005 for efficacy.

I digress.

I expect to hear something along the lines of "strong results".

After the bear raid, during the conference, I will likely have a tight stop.